Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/1999
12/01/1999EP0960626A2 Implantable solution application device and actuator for a syringe for filling the device
12/01/1999EP0960621A2 Pharmaceutical formulations comprising sildenafil
12/01/1999EP0960620A1 A stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole
12/01/1999EP0960619A1 Sustained release analgesic compositions comprising tilidine
12/01/1999EP0960618A2 Compositions of clindamycin and benzoyl peroxide for acne treatment
12/01/1999EP0960192A1 Synthetic polynucleotides
12/01/1999EP0960139A1 Elastomer treatment process to decrease peroxide levels
12/01/1999EP0960131A1 Manufacture of cross-linked amylose useful as an excipient for control release of active compounds
12/01/1999EP0959941A1 Electro-release systems, modified electrodes and their use
12/01/1999EP0959891A1 Anthelmintic formulations
12/01/1999EP0959880A1 Pharmaceutical formulation
12/01/1999EP0959876A2 Method for separating active substances in solid pharmaceutical preparations
12/01/1999EP0959875A1 Active substance carrier for releasing apomorphine into the buccal cavity
12/01/1999EP0959874A1 High dose liposomal aerosol formulations
12/01/1999EP0959873A2 Gel composition and methods
12/01/1999EP0959872A1 Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth
12/01/1999EP0959834A1 Method for producing transdermal patches (tts)
12/01/1999EP0831773B1 Peptide/protein suspended formulations
12/01/1999EP0783302B1 Medicaments
12/01/1999EP0739201B1 Microgranules of 5-nitro imidazole derivatives
12/01/1999EP0725642B1 Stabilized prostaglandin e 1
12/01/1999EP0697866B1 High dose formulations
12/01/1999EP0667782B1 Reconstituted platelet membrane vesicles
12/01/1999CN2351132Y Bougie for treating vaginitis
12/01/1999CN1237106A Stable medicinal compositions containing 4,5-epoxymorphinane derivatives
12/01/1999CN1237104A Fast decomposing pellets
12/01/1999CN1237103A Solid foamed active substance preparations
12/01/1999CN1237102A Liposomes
12/01/1999CN1237091A Composition comprising liquid absorbed on support based on precipitate silica
12/01/1999CN1236641A Process for preparing onychomycosis ointment
12/01/1999CN1236640A Process for preparing medicinal powder for onychomycosis
12/01/1999CN1236633A Powdered medicine for treating beriberi
12/01/1999CN1236631A Chinese patent medicine for treating ovarian cyst and its preparing process
12/01/1999CN1236627A Process for preparing interior-applied medicine to treat hyperosteogeny
12/01/1999CN1236626A Medicinal capsule for suppressing tumour and its preparing process
12/01/1999CN1236625A Antiphogistic and antalgic plaster
12/01/1999CN1236622A Medicine for treating intractable ulcer and its preparing process
12/01/1999CN1236614A Acetazolamide microemulsion as eyedrops for treating glaucoma and its preparing process
12/01/1999CN1046945C Azrinomycin sodium dihydrogen phosphate complex salt and its preparation
12/01/1999CN1046852C Process for preparing microspheroidal composition for non-enterogastric area of warm blooded animal
12/01/1999CN1046851C Process for preparing solid oral forms containing isocyclo-phosphoamide as active substance
11/1999
11/30/1999USRE36420 Percutaneous preparation of tulobuterol
11/30/1999USRE36419 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
11/30/1999US5994492 Microgels
11/30/1999US5994395 Composition for controlling parasites
11/30/1999US5994348 Pharmaceutical compositions containing irbesartan
11/30/1999US5994341 Anti-angiogenic Compositions and methods for the treatment of arthritis
11/30/1999US5994339 Oxidant scavengers
11/30/1999US5994338 Stabilized pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation
11/30/1999US5994326 Using raffinose
11/30/1999US5994325 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
11/30/1999US5994324 Water-soluble vitamin composition having excellent tablet properties and process for production thereof
11/30/1999US5994318 Complex; administering biologically active material
11/30/1999US5994314 Compositions and methods for nucleic acid delivery to the lung
11/30/1999US5993972 Improved amphiphilic diol is prepared with a controlled type and amount of alkylene glycol, catalyst, hydrophobic and hydrophilic diol with diisocyanate and water.
11/30/1999US5993888 Protein of gelatin and a water-soluble albumin, a carbohydrate, and a phospholipid in the form of a water-insoluble complex coacervate
11/30/1999US5993867 Capsules containing freeze-dried, powdered green tea leaves
11/30/1999US5993863 Contains sugars, amino acids, electrolytes and a fat emulsion at a specific mixing ratio and has a specific ph value and a titratable acidity.
11/30/1999US5993860 Powdered hydrocolloid gum obtainable from higher plants; dispersion-enhancing; and nsaid. exhibits a mucosal protective effect
11/30/1999US5993859 Pharmaceutical agents
11/30/1999US5993858 Method and formulation for increasing the bioavailability of poorly water-soluble drugs
11/30/1999US5993856 Pharmaceutical preparations and methods for their administration
11/30/1999US5993855 Microspheres prepared by emulsifying an aqueous phase containing a drug and an oil phase containing a biodegradable polylactide to form a w/o emulsion, and then mixing and agitating this emulsion with another aqueous phase to form a
11/30/1999US5993854 Exothermic effervescent composition for improved fragrance dispersion
11/30/1999US5993853 Reaction product of sodium bicarbonate and apple cider vinegar which is lyophilized.
11/30/1999US5993852 The immunogen is entrapped in lipid vesicles having a oil-in-water emulsion in the central core compartment.
11/30/1999US5993851 Mixing an oil-in-water emulsion with vesicle-forming lipids to form liposomes having a lipid-bilayer membrane composed of the vesicle-forming lipids and containing the oil-in-water emulsion in the central core compartment.
11/30/1999US5993850 Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
11/30/1999US5993849 85-99.9 weight % of (meth)acrylate copolymer from monomers having tertiary or quaternary amino groups, (b) 0.1-15 weight % of an organic dicarboxylic or tricarboxylic acid, and (c) 40-70 weight % of a plasticizer.
11/30/1999US5993846 Bioadhesive emulsion preparations for enhanced drug delivery
11/30/1999US5993845 Histone deacetylase inhibitor and a pharmaceutically acceptable carrier wherein the composition comprises from 0.05 to 100 mg of the histone deacetylase inhibitor.
11/30/1999US5993841 Treating or disorder of the nervous system comprising topically applying an antibiotic; an antihistamine; and a carrier; wherein said antibiotic and said antihistamine are present in relative amounts of 30:70 to 70:30% by weight
11/30/1999US5993838 Strip includes a flexible substrate sheet onto which a composition containing an adhesive polymer is deposited; treated to become dry non-tacky to the touch yet upon being wetted for use the composition again turns tacky and mobile.
11/30/1999US5993836 Topical anesthetic formulation
11/30/1999US5993831 Nanocapsules of a nonbiodegradable polymer encapsulating an oily phase containing an effective active oil or an oil having anti-free radical activity
11/30/1999US5993830 Combining a fatty acid, triethanolamine, propylene glycol, polyvinylpyrrolidone, polydimethylsiloxane, and either glycerol, sorbitol or polyethylene glycol
11/30/1999US5993806 Method of stabilizing pharmaceutical preparations comprising digestive enzyme mixtures
11/30/1999US5993805 Spray-dried microparticles and their use as therapeutic vehicles
11/30/1999US5993803 Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
11/30/1999US5993790 Containing a preservative, urea, and a natural additive
11/30/1999US5993786 Anti-carious chewing gums, candies, gels, toothpastes and dentifrices
11/30/1999US5993783 Aerosols
11/30/1999US5993782 Therapeutic method for reversing hyposmia in a human patient
11/30/1999US5993781 Fluticasone propionate nebulizable formulations
11/30/1999US5993414 Implantable device
11/30/1999CA2239331C Pharmaceutical tablets comprising cefuroxime axetil
11/30/1999CA2186588C Novel cationic phospholipids for transfection
11/30/1999CA2180648C Aqueous topical anti-acne compositions of low ph
11/30/1999CA2180530C Transdermal device containing polyvinylpyrrolidone as solubility enhancer
11/30/1999CA2166774C Pharmaceutical composition for immunomodulating and adjuvant treatment
11/30/1999CA2103060C Penetration-promoting substance
11/30/1999CA2007764C Salsalate tablet
11/26/1999CA2272840A1 Association of a retinoid with a histidine derivative
11/25/1999WO1999060167A1 Compositions and methods for topical delivery of oligonucleotides
11/25/1999WO1999060120A2 Soluble t cell receptor
11/25/1999WO1999060119A2 Multivalent t cell receptor complexes
11/25/1999WO1999060105A1 Flat sheet cell encapsulation device
11/25/1999WO1999060095A2 Formation and metallization of high aspect ratio lipid microtubules
11/25/1999WO1999060012A1 Compositions and methods for non-parenteral delivery of oligonucleotides
11/25/1999WO1999060008A1 Cytosine deaminase gene
1 ... 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 ... 2991